National Survey on Drug Use and Health: Clinical Validation Study of Substance Abuse and Dependence Measures

ICR 200112-0930-002

OMB: 0930-0231

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
ICR Details
0930-0231 200112-0930-002
Historical Active
HHS/SAMHSA
National Survey on Drug Use and Health: Clinical Validation Study of Substance Abuse and Dependence Measures
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 02/21/2002
Retrieve Notice of Action (NOA) 12/18/2001
Approved consistent with changes detailed in memos dated 2/13 and 2/14/02. In addition, SAMHSA is allowed to collect the "main race" question consistent with previous terms of clearance for the main study (0930-0110). SAMHSA shall report the results of the 2001 data collection on main race as soon as possible, as specified in the previous terms of clearance on the main study. This main race data collection shall cease in 2003, and SAMHSA is not allowed to use this main race question in any of its other surveys. In addition, in the memo dated 2/14/02, SAMHSA indicated that recruitment materials for adolescents that are not currently in treatment for drug or alcohol abuse will be sent to OMB for review and approval prior to use in the study. Approval for the adolescent module is contingent on review and clearance of these materials.
  Inventory as of this Action Requested Previously Approved
02/28/2005 02/28/2005
695 0 0
723 0 0
0 0 0

This methodological study will be a three-phased clinical validation study of the substance abuse and dependence module of the National Survey on Drug Use and Health. The first phase will determine psychometric properties of the current module. If it is determined that the diagnosis of substance abuse and dependence developed from the module does not sufficiently correspond with the diagnosis developed from a structured clinical interview assessment, the module will be modified and the psychometric properties of a revised module will be tested as the second phase. A third pahse, if.........

None
None


No

1
IC Title Form No. Form Name
National Survey on Drug Use and Health: Clinical Validation Study of Substance Abuse and Dependence Measures

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 695 0 0 695 0 0
Annual Time Burden (Hours) 723 0 0 723 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
Yes Part B of Supporting Statement
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/18/2001


© 2024 OMB.report | Privacy Policy